Prosecution Insights
Last updated: October 02, 2026

Examiner: SAIDHA, TEKCHAND

Tech Center 3600 • Art Units: 1652 1654 1655 1656 1663 1692 1699 3683

This examiner grants 83% of resolved cases

Analysis

Tekchand Saidha is a patent examiner in Tech Center 3600, assigned to Art Unit 1652. He has 1068 resolved cases. The data shows an allowance rate of 82.9% for these 1068 cases. This 82.9% figure represents the frequency of grants among all resolved cases for this examiner.

The interview lift for Tekchand Saidha is 14.1%. This 14.1% lift indicates the change in the probability of allowance when an interview is conducted during prosecution. Practitioners can use this lift to evaluate the potential impact of oral advocacy on their specific applications in Art Unit 1652.

The median days to allowance is 856. This 856 day period measures the time from the filing of an application to the issuance of a patent. This median provides a data point for estimating the duration of the examination process for matters assigned to this examiner.

Practitioners should consider the 82.9% allowance rate and the 14.1% interview lift when developing their response strategies. These figures, along with the 856 day median, offer a statistical overview of the examiner's history in Tech Center 3600.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

82.9%
Allow Rate
+30.9% vs TC avg
1,098
Total Applications
+14.1%
Interview Lift
857
Avg Prosecution Days
Based on 1069 resolved cases, 2023–2026

Rejection Statute Breakdown

7.5%
§101 Eligibility
20.4%
§102 Novelty
13.9%
§103 Obviousness
40.7%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18890599 CLOSTRIDIUM BOTULINUM NEUROTOXIN SEROTYPE A COMPOSITIONS Non-Final OA AbbVie Inc.
18743376 MICROORGANISMS AND METHODS FOR PRODUCING REUTERIN Non-Final OA Wisconsin Alumni Research Foundation
18279423 PREDICTION OF PREECLAMPSIA RISK USING CIRCULATING, CELL-FREE RNA Non-Final OA THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
18167711 Methods and Materials for Producing Polyols and Electron Rich Compounds Non-Final OA THE TRUSTEES OF PRINCETON UNIVERSITY
18874257 SEPARATION OF HUMAN MILK OLIGOSACCHARIDES FROM A FERMENTATION BROTH Non-Final OA DSM IP ASSETS B.V.
18553801 ENZYME COMPOSITION Final Rejection DSM IP Assets B.V.
18650149 METHODS OF TAGGING RNA MOLECULES ASSOCIATED WITH EPIGENETICALLY MODIFIED CHROMATIN IN LIVING CELLS Non-Final OA City University of Hong Kong
18626205 PSEUDOMONAS PUTIDA STRAINS ENGINEERED FOR PRODUCTION OF MUCONIC ACID FROM P-METHOXYLATED BENZOIC ACIDS Final Rejection Alliance for Energy Innovation, LLC
18546920 ENGINEERED THERMOSTABLE CARBONIC ANHYDRASE ENZYMES Final Rejection Alliance for Energy Innovation, LLC
18718573 TESTS AND METHODS FOR DETECTING BACTERIAL INFECTION Non-Final OA Heraeus Medical GmbH
18123968 EFFICIENT PRODUCTION OF CIS, CIS-MUCONIC ACID FROM MIXED SUBSTRATES OF GLUCOSE, D-XYLOSE AND L-ARABINOSE Final Rejection UT-Battelle, LLC
18856085 METHOD FOR PREPARING ALPHA-BRANCHED BETA'-HYDROXY CARBONYL COMPOUNDS BY ENZYMATIC-CATALYZED REDUCTIVE ALDOL REACTION Non-Final OA Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.
18717153 METHOD FOR PRODUCING AROMATIC COMPOUND Non-Final OA KAO CORPORATION
18826915 DETERGENT COMPOSITIONS Final Rejection Novozymes A/S
18716115 IMPROVED PROTEIN PRODUCTION IN RECOMBINANT BACTERIA Non-Final OA Novozymes A/S
18937302 THIOESTERASE VARIANTS HAVING IMPROVED ACTIVITY FOR THE PRODUCTION OF MEDIUM-CHAIN FATTY ACID DERIVATIVES Non-Final OA Genomatica, Inc.
18701533 ALDEHYDE DEHYDROGENASE VARIANTS AND METHODS OF USE Non-Final OA Genomatica, Inc.
18687169 FLAVIN-DEPENDENT OXIDASES HAVING CANNABINOID SYNTHASE ACTIVITY Non-Final OA GENOMATICA, INC.
18720596 WHOOPING COUGH ANTIGEN RECOMBINANT EXPRESSION VECTOR, AND ENGINEERED STRAIN AND USE THEREOF Non-Final OA GRAND THERAVAC LIFE SCIENCE (NANJING) CO., LTD.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month